129 related articles for article (PubMed ID: 21235283)
1. Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality.
Sun J; Miller JM; Beig A; Rozen L; Amidon GL; Dahan A
Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):313-23. PubMed ID: 21235283
[TBL] [Abstract][Full Text] [Related]
2. Ontogeny of oral drug absorption processes in children.
Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
[TBL] [Abstract][Full Text] [Related]
3. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
Cho HJ; Kim JE; Kim DD; Yoon IS
Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
[TBL] [Abstract][Full Text] [Related]
4. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
5. Experimental models for predicting drug absorption and metabolism.
Alqahtani S; Mohamed LA; Kaddoumi A
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
[TBL] [Abstract][Full Text] [Related]
6. Ligand-mediated active targeting for enhanced oral absorption.
Zhang X; Wu W
Drug Discov Today; 2014 Jul; 19(7):898-904. PubMed ID: 24631680
[TBL] [Abstract][Full Text] [Related]
7. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
8. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.
del Amo EM; Heikkinen AT; Mönkkönen J
Eur J Pharm Sci; 2009 Feb; 36(2-3):200-11. PubMed ID: 19063964
[TBL] [Abstract][Full Text] [Related]
9. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
10. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
Raaflaub J
Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
[TBL] [Abstract][Full Text] [Related]
11. An interesting relationship between drug absorption and melting point.
Chu KA; Yalkowsky SH
Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
[TBL] [Abstract][Full Text] [Related]
12. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
Heikkinen AT; Korjamo T; Mönkkönen J
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
[TBL] [Abstract][Full Text] [Related]
13. Bile salts and their importance for drug absorption.
Holm R; Müllertz A; Mu H
Int J Pharm; 2013 Aug; 453(1):44-55. PubMed ID: 23598075
[TBL] [Abstract][Full Text] [Related]
14. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
15. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.
Hurst S; Loi CM; Brodfuehrer J; El-Kattan A
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):469-89. PubMed ID: 17696800
[TBL] [Abstract][Full Text] [Related]
16. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of proteins by biodegradable nanoparticles.
Bakhru SH; Furtado S; Morello AP; Mathiowitz E
Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
[TBL] [Abstract][Full Text] [Related]
18. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
20. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
Shahbazi MA; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
